GOLDENWELL BIOTECH, INC. financial data

Symbol
GWLL on OTC
Location
Solon, OH
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 08 Dec 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -386% % -191%
Return On Equity 365% % 77%
Return On Assets -128% % -409%
Operating Margin -90949% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99,000,000 shares 0%
Common Stock, Shares, Outstanding 99,000,000 shares 0%
Entity Public Float $9,600,000 USD -24%
Common Stock, Value, Issued $9,900 USD 0%
Weighted Average Number of Shares Outstanding, Diluted 96,433,333 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Revenue from Contract with Customer, Excluding Assessed Tax $557 USD -73%
Cost of Revenue $6 USD -98%
General and Administrative Expense $129,133 USD 8.8%
Operating Income (Loss) $66,639 USD 44%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $34,377 USD -11%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $283,041 USD -440%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $25,720 USD
Inventory, Net $174,788 USD 0.06%
Operating Lease, Right-of-Use Asset $0 USD
Assets $220,410 USD 23%
Accounts Payable, Current $0 USD
Liabilities, Current $39,360 USD
Other Liabilities, Noncurrent $189,250 USD
Liabilities $315,233 USD 59%
Retained Earnings (Accumulated Deficit) $1,407,226 USD -5.7%
Stockholders' Equity Attributable to Parent $94,823 USD -593%
Liabilities and Equity $220,410 USD 23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $59,380 USD
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 99,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $45,622 USD 859%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $285,527 USD 11%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability, Current $0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $21,565 USD
Deferred Tax Assets, Operating Loss Carryforwards $295,518 USD 5.7%
Additional Paid in Capital $1,302,504 USD 0%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $8,400 USD 0%